This page shows the latest Cipralex news and features for those working in and with pharma, biotech and healthcare.
mature products like epilepsy therapies Onfi (clobazam) and Sabril (vigabatrin) and antidepressant Cipralex (escitalopram).
Sales of antidepressant Cipralex (escitalopram) and anti-epileptic Sabril (vigabatrin) also suffered double-digit declines, more than offsetting growth of Lundbeck’s four strategic brands.
Two newer antidepressants help boost sales after Cipralex patent ends. Surging sales of four new central nervous system drugs helped Denmark's Lundbeck post a 5% sales increase in the second ... Those gains were encouraging and helped offset the
sales from drugs such as depression treatment Cipralex (escitalopram).
Brintellix has been on the market in the US since 2013 and has been positioned as a successor to its older antidepressant Cipralex (escitalopram), which was selling around $2bn a year
to continued generic competition to Alzheimer's therapy Ebixa (memantine) and antidepressant Cipralex (escitalopram). ... The company's newer drugs will need to pick up the pace to offset the impact of genericisation however, given that Cipralex sales
More from news
Approximately 3 fully matching, plus 35 partially matching documents found.
Fredrik Jerre,. Head of Global Marketing,. Cipralex, Lundbeck.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...